pharmaceutical investing Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan
Spartan Metals Corp Retains Strategic Government Relations Firm to Advance Non-Dilutive Funding Opportunities